Safety and efficacy of fixed-dose heparin in carotid endarterectomy

Neurosurgery

Volumn 45, Issue 3, 1999, Pages 434-442

  Poisik, Alexander ^a   Heyer, Eric J ^a   Solomon, Robert A ^a   Quest, Donald O ^a   Adams, David C ^a   Baldasserini, Catherine Moses ^a   McMahon, Donald J ^a   Huang, Judy ^a   Kim, Louis J ^a   Choudhri, Tanvir F ^a   Connolly, E Sander ^a,b  

^a Howard Hughes Medical Institute   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Activated clotting time; Carotid endarterectomy; Heparin; Monitoring

Indexed keywords

HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CAROTID ENDARTERECTOMY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH CARE COST; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSYCHOPATHY; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0032840733     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199909000-00003     Document Type: Article

References (26)

1. Adams RD, Victor M: Principles of Neurology. New York, McGraw-Hill, 1985, ed 2.
2. Aldea GS, O'Gara, P, Shapira OM, Treanor P, Osman A, Patalis E, Arkin C, Diamond R, Babikian V, Lazar HL, Shemin RJ: Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg 65:425-433, 1998.
3. Best CH: Preparation of heparin and its use in the first clinical case. Circulation 19:79-86, 1959.
4. Bull BS, Huse WM, Brauer FS, Korpman RA: Heparin therapy during extracorporeal circulation: II - The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 69:685-689, 1975.
5. Bull BS, Korpman RA, Huse WM, Briggs BD: Heparin therapy during extracorporeal circulation: I - Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 69:674-684, 1975.
6. Buschke H, Fuld PA: Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24:1019-1025, 1974.
7. Cantelmo NL, Babikian VL, Samaraweera RN, Gordon JK, Pochay VE, Winter MR: Cerebral microembolism and ischemic changes associated with carotid endarterectomy. J Vasc Surg 27:1024-1030, 1998.
8. Cipolle RJ, Uden DL, Gruber SA, Jossart GH, Taylor CA, Erdmann GR: Evaluation of a rapid monitoring system to study heparin pharmacokinetics and pharmacodynamics. Pharmacotherapy 10:367-372, 1990.
9. Connolly ES: Proinflammatory microvascular failure in reperfused stroke. Presented at the 60th Annual Meeting of the American Academy of Neurological Surgery, Santa Barbara, CA, November 7, 1998.
10. Coyne TJ, Wallace C, Benedict C: Peri-operative anticoagulant effects of heparinization for carotid endarterectomy. Aust N Z J Surg 64:679-683, 1994.
11. Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics. New York, Macmillan, 1975, ed 5.
12. Green TP, Isham-Schopf B, Steinhorn RH, Smith C, Irmiter RJ: Whole blood activated clotting time in infants during extracorporeal membrane oxygenation. Crit Care Med 18:494-498, 1990.
13. Heyer EJ, Adams DC, Solomon RA, Todd GJ, Quest DO, McMahon DJ, Steneck SD, Choudhri TF, Connolly ES Jr: Neuropsychometric changes in patients after carotid endarterectomy. Stroke 29:1110-1115, 1998.
14. Hirsh J, Dalen JE, Deykin D, Poller L: Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 102[Suppl]:S337-S351, 1992.
15. Lezak MD: Neuropsychological Assessment. New York, Oxford University Press, 1995, ed 3.
16. Mabry CD, Thompson BW, Read RC: Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery. Am J Surg 138:884-890, 1979.
17. Mattox KL, Guinn GA, Rubio PA, Beall AC Jr: Use of the activated coagulation time in intraoperative heparin reversal for cardiopulmonary operations. Ann Thorac Surg 19:634-638, 1975.
18. McLean J: The thromboplastic action of cephalin. Am J Physiol 41:250-257, 1916.
19. Melandri G, Branzi A, Traini AM, Semprini F, Cervi V, Magnani B: On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes. Am J Cardiol 71:469-471, 1993.
20. Nath FC, Muller DW, Rosenchein U, Ellis SG, Topol EJ: Heparin monitoring during coronary intervention: Activated clotting time versus activated partial thromboplastin time. Can J Cardiol 9:797-801, 1993.
21. Reiner JS, Coyne KS, Lundergan CF, Ross AM: Bedside monitoring of heparin therapy: Comparison of activated clotting time to activated partial thromboplastin time. Cathet Cardiovasc Diagn 32:49-52, 1994.
22. Rosenwasser RH, Garrido E, Freed MH, Shupak RC: Monitoring of activated clotting time during carotid endarterectomy: A preliminary report. Neurosurgery 9:521-523, 1981.
23. Simko RJ, Tsung FFW, Stanek EJ: Activated clotting time versus activated partial thromboplastin time for therapeutic monitoring of heparin. Ann Pharmacother 29:1015-1021, 1995.
24. Treiman RL, Crossman DV, Foran RF, Levin PM, Cohen JL, Wagner WH: The influence of neutralizing heparin after carotid endarterectomy on postoperative stroke and wound hematoma. J Vasc Surg 12:440-446, 1990.
25. Vanninen E, Vanninen R, Aikia M, Tulla H, Kononen M, Koivisto K, Partanen K, Hippelainen M, Kuikka JT: Frequency of carotid endarterectomy-related subclinical cerebral complications. Cerebrovasc Dis 6:272-280, 1996.
26. Welling RE, Ramadas HS, Gansmuller KJ: Cervical wound hematoma after carotid endarterectomy. Ann Vasc Surg 3:229-331, 1989.